Contra-indicated in patients with chronic, severe kidney disease or acute kidney injury.
- TRADE NAME: Omniscan (Mallinckrodt)
- INDICATIONS: Magnetic resonance imaging (MRI)
- CLASS: Diagnostic aid, Magnetic resonance imaging contrast medium
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
NOT FOR INTRATHECAL USE and NEPHROGENIC SYSTEMIC FIBROSIS (NSF)
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
